Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Nutr Biochem. 2017 Nov 4;54:77–86. doi: 10.1016/j.jnutbio.2017.10.015

Figure 3. Effect of pharmacological ERK1/2 inhibition on resveratrol- and pinostilbene-mediated protection from DA-induced ATP loss in SH-SY5Y cells.

Figure 3

U0126 (10 µM) inhibited the (B) resveratrol- and (C) pinostilbene-mediated protection from 100 µM DA-induced ATP loss. n=3–4 experiments done in triplicate for each group. Data are expressed as mean ± SEM. **** p < 0.0001 and *** p < 0.001 compared to DMSO treatment.